Subscribe to RSS
DOI: 10.4103/ijmpo.ijmpo_142_18
Histopathological Spectrum of Bone Changes in Skeletal Metastasis
Financial support and sponsorship Nil.
Abstract
Background: Metastatic carcinoma is the most common secondary malignant tumor affecting the bone. Bone is the third most common site for metastasis after lung and liver. The present study was planned to analyze the histomorphological patterns of bone changes in metastatic tumors and their correlation with the radiological findings. Materials and Methods: The current prospective study was conducted over a span of 2 years, encompassing 150 patients with clinically and radiologically suspected metastatic bone disease. Bone biopsy samples were studied for the pattern of bone changes. Results: Of 150 total cases, 30 cases had metastatic bone tumors. The age of the patients ranged from 37 to 84 years (mean: 57.57 ± 11.9 years). Male-to-female ratio was 2:1. All patients with metastasis presented with a complaint of pain followed by tenderness (20, 66.7%). The lesions were commonly located in the vertebral column (14, 46.7%), followed by femur (6, 20%). The primary site was known in 21 (70%) cases. The tumor histotypes were adenocarcinoma (23, 76.7%), squamous cell carcinoma (5, 16.7%), pleomorphic sarcoma (1, 3.3%), and malignant melanoma (1, 3.3%). Histomorphological patterns of bone changes were osteolytic (16, 53.3%), mixed (8, 26.7%), and osteoblastic (6, 20.0%). Correlation between the radiological findings and histopathological patterns of metastases was found to be statistically significant. Conclusions: Histomorphological assessment of bone changes in metastasis is an important parameter. Besides the histological categorization of metastatic bone disease, it plays a pivotal role in identification of the primary tumor site.
Publication History
Received: 26 June 2018
Accepted: 29 November 2018
Article published online:
03 June 2021
© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Rougraff BT. Evaluation of the patient with carcinoma of unknown origin metastatic to bone. Clin Orthop Relat Res 2003; 415: S105-9
- 2 Mundy GR. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2: 584-93
- 3 O’Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: An update. World J Radiol 2015; 7: 202-11
- 4 Salmon JM, Kilpatrick SE. Pathology of skeletal metastases. Orthop Clin North Am 2000; 31: 537-44 vii-viii
- 5 Disibio G, French SW. Metastatic patterns of cancers: Results from a large autopsy study. Arch Pathol Lab Med 2008; 132: 931-9
- 6 Fidler IJ, Poste G. The “seed and soil” hypothesis revisited. Lancet Oncol 2008; 9: 808
- 7 Kakhki VR, Anvari K, Sadeghi R, Mahmoudian AS, Torabian-Kakhki M. Pattern and distribution of bone metastases in common malignant tumors. Nucl Med Rev Cent East Eur 2013; 16: 66-9
- 8 Virk MS, Lieberman JR. Tumor metastasis to bone. Arthritis Res Ther 2007; 9 (01) Suppl S5
- 9 Stomeo D, Tulli A, Ziranu A, Perisano C, De Santis V, Maccauro G. et al. Acrometastasis: A literature review. Eur Rev Med Pharmacol Sci 2015; 19: 2906-15
- 10 Piccioli A, Maccauro G, Spinelli MS, Biagini R, Rossi B. Bone metastases of unknown origin: Epidemiology and principles of management. J Orthop Traumatol 2015; 16: 81-6
- 11 Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12: 6243s-9s
- 12 Vukmirovic-Popovic S, Colterjohn N, Lhoták S, Duivenvoorden WC, Orr FW, Singh G. Morphological, histomorphometric, and microstructural alterations in human bone metastasis from breast carcinoma. Bone 2002; 31: 529-35
- 13 Burkhardt R, Frisch B, Schlag R, Sommerfeld W. Carcinomatous osteodysplasia. Skeletal Radiol 1982; 8: 169-78
- 14 Ridell B, Landys K. Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest. Cancer 1979; 44: 1782-8
- 15 Chappard D, Bouvard B, Baslé MF, Legrand E, Audran M. Bone metastasis: Histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review. Morphologie 2011; 95: 65-75
- 16 Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350: 1655-64
- 17 Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L. et al. Bone metastases: An overview. Oncol Rev 2017; 11: 321
- 18 Yin JJ, Pollock CB, Kelly K. Mechanisms of cancer metastasis to the bone. Cell Res 2005; 15: 57-62
- 19 Coleman RE. Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27: 165-76
- 20 Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ. et al. Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone. Cancer Metastasis Rev 2001; 20: 333-49
- 21 Cuccurullo V, Cascini GL, Tamburrini O, Rotondo A, Mansi L. Bone metastases radiopharmaceuticals: An overview. Curr Radiopharm 2013; 6: 41-7
- 22 Choi J, Raghavan M. Diagnostic imaging and image-guided therapy of skeletal metastases. Cancer Control 2012; 19: 102-12
- 23 Messiou C, Cook G, deSouza NM. Imaging metastatic bone disease from carcinoma of the prostate. Br J Cancer 2009; 101: 1225-32
- 24 James JJ, Evans AJ, Pinder SE, Gutteridge E, Cheung KL, Chan S. et al. Bone metastases from breast carcinoma: Histopathological-radiological correlations and prognostic features. Br J Cancer 2003; 89: 660-5